Introduction: Dengue virus is a global health threat, with approximately 390 million dengue
infections annually. Efficient vaccines for dengue prevention are currently lacking. This …

Recombinant proteins are gaining enormous importance these days due to their wide
application as biopharmaceutical products and proven safety record. Various recombinant …

Flaviviruses are enveloped single positive-stranded RNA viruses. The capsid (C), a
structural protein of flavivirus, is dimeric and alpha-helical, with several special structural …

Dengue viruses are emerging mosquito-borne pathogens belonging to Flaviviridae family
which are transmitted to humans via the bites of infected mosquitoes Aedes aegypti and …

Dengue virus (DENV) is a global health threat causing about half of the worldwide
population to be at risk of infection, especially the people living in tropical and subtropical …

A peptide from the P0 acidic ribosomal protein (pP0) of ticks conjugated to keyhole limpet
hemocyanin from Megathura crenulata has shown to be effective against different tick …

Dengue represents a significant and growing public health problem across the globe, with
approximately half of the world's population at risk. The increasing and expanding burden of …

Our group developed a subunit vaccine candidate against dengue virus based on two
different viral regions: the domain III of the envelope protein and the capsid protein. The …

Dengue fever, an infectious disease that affects more than 100 million people every year, is
a global health problem. Vaccination may be the most effective prevention strategy for the …

The dengue virus (DENV) causes dengue infection and has become a significant global
public health concern. The successful application of immunotherapies in treating dengue …